| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |